The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Albendazole Anthelmintic Drug Market Research Report 2025
Synopsis
Albendazole is an anthelmintic drug used to treat parasitic infections caused by various types of worms and helminths. It works by inhibiting the parasites' ability to absorb nutrients, ultimately causing their death. Albendazole is commonly used to treat conditions like intestinal worms, strongyloidiasis, and neurocysticercosis.
The global Albendazole Anthelmintic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Albendazole Anthelmintic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albendazole Anthelmintic Drug.
Report Scope
The Albendazole Anthelmintic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Albendazole Anthelmintic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albendazole Anthelmintic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
Segment by Type
Tablet
Capsule
Other
Segment by Application
Human
Veterinary
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albendazole Anthelmintic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albendazole Anthelmintic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Albendazole is an anthelmintic drug used to treat parasitic infections caused by various types of worms and helminths. It works by inhibiting the parasites' ability to absorb nutrients, ultimately causing their death. Albendazole is commonly used to treat conditions like intestinal worms, strongyloidiasis, and neurocysticercosis.
The global Albendazole Anthelmintic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Albendazole Anthelmintic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albendazole Anthelmintic Drug.
Report Scope
The Albendazole Anthelmintic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Albendazole Anthelmintic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albendazole Anthelmintic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
Segment by Type
Tablet
Capsule
Other
Segment by Application
Human
Veterinary
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albendazole Anthelmintic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albendazole Anthelmintic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Albendazole Anthelmintic Drug Market Overview
1.1 Product Overview and Scope of Albendazole Anthelmintic Drug
1.2 Albendazole Anthelmintic Drug Segment by Type
1.2.1 Global Albendazole Anthelmintic Drug Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Albendazole Anthelmintic Drug Segment by Application
1.3.1 Global Albendazole Anthelmintic Drug Market Value by Application: (2024-2030)
1.3.2 Human
1.3.3 Veterinary
1.4 Global Albendazole Anthelmintic Drug Market Size Estimates and Forecasts
1.4.1 Global Albendazole Anthelmintic Drug Revenue 2019-2030
1.4.2 Global Albendazole Anthelmintic Drug Sales 2019-2030
1.4.3 Global Albendazole Anthelmintic Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Albendazole Anthelmintic Drug Market Competition by Manufacturers
2.1 Global Albendazole Anthelmintic Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Albendazole Anthelmintic Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Albendazole Anthelmintic Drug Average Price by Manufacturers (2019-2024)
2.4 Global Albendazole Anthelmintic Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Albendazole Anthelmintic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Albendazole Anthelmintic Drug, Product Type & Application
2.7 Albendazole Anthelmintic Drug Market Competitive Situation and Trends
2.7.1 Albendazole Anthelmintic Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Albendazole Anthelmintic Drug Players Market Share by Revenue
2.7.3 Global Albendazole Anthelmintic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Albendazole Anthelmintic Drug Retrospective Market Scenario by Region
3.1 Global Albendazole Anthelmintic Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Albendazole Anthelmintic Drug Global Albendazole Anthelmintic Drug Sales by Region: 2019-2030
3.2.1 Global Albendazole Anthelmintic Drug Sales by Region: 2019-2024
3.2.2 Global Albendazole Anthelmintic Drug Sales by Region: 2025-2030
3.3 Global Albendazole Anthelmintic Drug Global Albendazole Anthelmintic Drug Revenue by Region: 2019-2030
3.3.1 Global Albendazole Anthelmintic Drug Revenue by Region: 2019-2024
3.3.2 Global Albendazole Anthelmintic Drug Revenue by Region: 2025-2030
3.4 North America Albendazole Anthelmintic Drug Market Facts & Figures by Country
3.4.1 North America Albendazole Anthelmintic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Albendazole Anthelmintic Drug Sales by Country (2019-2030)
3.4.3 North America Albendazole Anthelmintic Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Albendazole Anthelmintic Drug Market Facts & Figures by Country
3.5.1 Europe Albendazole Anthelmintic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Albendazole Anthelmintic Drug Sales by Country (2019-2030)
3.5.3 Europe Albendazole Anthelmintic Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Albendazole Anthelmintic Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Albendazole Anthelmintic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Albendazole Anthelmintic Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Albendazole Anthelmintic Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Albendazole Anthelmintic Drug Market Facts & Figures by Country
3.7.1 Latin America Albendazole Anthelmintic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Albendazole Anthelmintic Drug Sales by Country (2019-2030)
3.7.3 Latin America Albendazole Anthelmintic Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Albendazole Anthelmintic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Albendazole Anthelmintic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Albendazole Anthelmintic Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Albendazole Anthelmintic Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Albendazole Anthelmintic Drug Sales by Type (2019-2030)
4.1.1 Global Albendazole Anthelmintic Drug Sales by Type (2019-2024)
4.1.2 Global Albendazole Anthelmintic Drug Sales by Type (2025-2030)
4.1.3 Global Albendazole Anthelmintic Drug Sales Market Share by Type (2019-2030)
4.2 Global Albendazole Anthelmintic Drug Revenue by Type (2019-2030)
4.2.1 Global Albendazole Anthelmintic Drug Revenue by Type (2019-2024)
4.2.2 Global Albendazole Anthelmintic Drug Revenue by Type (2025-2030)
4.2.3 Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2019-2030)
4.3 Global Albendazole Anthelmintic Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Albendazole Anthelmintic Drug Sales by Application (2019-2030)
5.1.1 Global Albendazole Anthelmintic Drug Sales by Application (2019-2024)
5.1.2 Global Albendazole Anthelmintic Drug Sales by Application (2025-2030)
5.1.3 Global Albendazole Anthelmintic Drug Sales Market Share by Application (2019-2030)
5.2 Global Albendazole Anthelmintic Drug Revenue by Application (2019-2030)
5.2.1 Global Albendazole Anthelmintic Drug Revenue by Application (2019-2024)
5.2.2 Global Albendazole Anthelmintic Drug Revenue by Application (2025-2030)
5.2.3 Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2019-2030)
5.3 Global Albendazole Anthelmintic Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Albendazole Anthelmintic Drug Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Huazhong Pharmaceutical
6.2.1 Huazhong Pharmaceutical Corporation Information
6.2.2 Huazhong Pharmaceutical Description and Business Overview
6.2.3 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio
6.2.5 Huazhong Pharmaceutical Recent Developments/Updates
6.3 Jiangsu Qihui
6.3.1 Jiangsu Qihui Corporation Information
6.3.2 Jiangsu Qihui Description and Business Overview
6.3.3 Jiangsu Qihui Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jiangsu Qihui Albendazole Anthelmintic Drug Product Portfolio
6.3.5 Jiangsu Qihui Recent Developments/Updates
6.4 Sequent Scientific
6.4.1 Sequent Scientific Corporation Information
6.4.2 Sequent Scientific Description and Business Overview
6.4.3 Sequent Scientific Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sequent Scientific Albendazole Anthelmintic Drug Product Portfolio
6.4.5 Sequent Scientific Recent Developments/Updates
6.5 K.A. Malle Pharmaceuticals
6.5.1 K.A. Malle Pharmaceuticals Corporation Information
6.5.2 K.A. Malle Pharmaceuticals Description and Business Overview
6.5.3 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product Portfolio
6.5.5 K.A. Malle Pharmaceuticals Recent Developments/Updates
6.6 Lasa Supergenerics Limited
6.6.1 Lasa Supergenerics Limited Corporation Information
6.6.2 Lasa Supergenerics Limited Description and Business Overview
6.6.3 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product Portfolio
6.6.5 Lasa Supergenerics Limited Recent Developments/Updates
6.7 Zhongjia Pharmaceutical
6.6.1 Zhongjia Pharmaceutical Corporation Information
6.6.2 Zhongjia Pharmaceutical Description and Business Overview
6.6.3 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio
6.7.5 Zhongjia Pharmaceutical Recent Developments/Updates
6.8 Fredun Pharmaceuticals Ltd
6.8.1 Fredun Pharmaceuticals Ltd Corporation Information
6.8.2 Fredun Pharmaceuticals Ltd Description and Business Overview
6.8.3 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product Portfolio
6.8.5 Fredun Pharmaceuticals Ltd Recent Developments/Updates
6.9 Supharma Chem
6.9.1 Supharma Chem Corporation Information
6.9.2 Supharma Chem Description and Business Overview
6.9.3 Supharma Chem Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Supharma Chem Albendazole Anthelmintic Drug Product Portfolio
6.9.5 Supharma Chem Recent Developments/Updates
6.10 Salius Pharma
6.10.1 Salius Pharma Corporation Information
6.10.2 Salius Pharma Description and Business Overview
6.10.3 Salius Pharma Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Salius Pharma Albendazole Anthelmintic Drug Product Portfolio
6.10.5 Salius Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Albendazole Anthelmintic Drug Industry Chain Analysis
7.2 Albendazole Anthelmintic Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Albendazole Anthelmintic Drug Production Mode & Process
7.4 Albendazole Anthelmintic Drug Sales and Marketing
7.4.1 Albendazole Anthelmintic Drug Sales Channels
7.4.2 Albendazole Anthelmintic Drug Distributors
7.5 Albendazole Anthelmintic Drug Customers
8 Albendazole Anthelmintic Drug Market Dynamics
8.1 Albendazole Anthelmintic Drug Industry Trends
8.2 Albendazole Anthelmintic Drug Market Drivers
8.3 Albendazole Anthelmintic Drug Market Challenges
8.4 Albendazole Anthelmintic Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Albendazole Anthelmintic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Albendazole Anthelmintic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Albendazole Anthelmintic Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Albendazole Anthelmintic Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Albendazole Anthelmintic Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Albendazole Anthelmintic Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Albendazole Anthelmintic Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Albendazole Anthelmintic Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Albendazole Anthelmintic Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Albendazole Anthelmintic Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Albendazole Anthelmintic Drug, Product Type & Application
Table 12. Global Key Manufacturers of Albendazole Anthelmintic Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Albendazole Anthelmintic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albendazole Anthelmintic Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Albendazole Anthelmintic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Albendazole Anthelmintic Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Albendazole Anthelmintic Drug Sales Market Share by Region (2019-2024)
Table 19. Global Albendazole Anthelmintic Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Albendazole Anthelmintic Drug Sales Market Share by Region (2025-2030)
Table 21. Global Albendazole Anthelmintic Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Albendazole Anthelmintic Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Albendazole Anthelmintic Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Albendazole Anthelmintic Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Albendazole Anthelmintic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Albendazole Anthelmintic Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Albendazole Anthelmintic Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Albendazole Anthelmintic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Albendazole Anthelmintic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Albendazole Anthelmintic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Albendazole Anthelmintic Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Albendazole Anthelmintic Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Albendazole Anthelmintic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Albendazole Anthelmintic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Albendazole Anthelmintic Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Albendazole Anthelmintic Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Albendazole Anthelmintic Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Albendazole Anthelmintic Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Albendazole Anthelmintic Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Albendazole Anthelmintic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Albendazole Anthelmintic Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Albendazole Anthelmintic Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Albendazole Anthelmintic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Albendazole Anthelmintic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Albendazole Anthelmintic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Albendazole Anthelmintic Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Albendazole Anthelmintic Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Albendazole Anthelmintic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Albendazole Anthelmintic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Albendazole Anthelmintic Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Albendazole Anthelmintic Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Albendazole Anthelmintic Drug Sales Market Share by Type (2019-2024)
Table 53. Global Albendazole Anthelmintic Drug Sales Market Share by Type (2025-2030)
Table 54. Global Albendazole Anthelmintic Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Albendazole Anthelmintic Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Albendazole Anthelmintic Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Albendazole Anthelmintic Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Albendazole Anthelmintic Drug Sales Market Share by Application (2019-2024)
Table 63. Global Albendazole Anthelmintic Drug Sales Market Share by Application (2025-2030)
Table 64. Global Albendazole Anthelmintic Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Albendazole Anthelmintic Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Application (2025-2030)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. GlaxoSmithKline Albendazole Anthelmintic Drug Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Huazhong Pharmaceutical Corporation Information
Table 76. Huazhong Pharmaceutical Description and Business Overview
Table 77. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product
Table 79. Huazhong Pharmaceutical Recent Developments/Updates
Table 80. Jiangsu Qihui Corporation Information
Table 81. Jiangsu Qihui Description and Business Overview
Table 82. Jiangsu Qihui Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Jiangsu Qihui Albendazole Anthelmintic Drug Product
Table 84. Jiangsu Qihui Recent Developments/Updates
Table 85. Sequent Scientific Corporation Information
Table 86. Sequent Scientific Description and Business Overview
Table 87. Sequent Scientific Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sequent Scientific Albendazole Anthelmintic Drug Product
Table 89. Sequent Scientific Recent Developments/Updates
Table 90. K.A. Malle Pharmaceuticals Corporation Information
Table 91. K.A. Malle Pharmaceuticals Description and Business Overview
Table 92. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product
Table 94. K.A. Malle Pharmaceuticals Recent Developments/Updates
Table 95. Lasa Supergenerics Limited Corporation Information
Table 96. Lasa Supergenerics Limited Description and Business Overview
Table 97. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product
Table 99. Lasa Supergenerics Limited Recent Developments/Updates
Table 100. Zhongjia Pharmaceutical Corporation Information
Table 101. Zhongjia Pharmaceutical Description and Business Overview
Table 102. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product
Table 104. Zhongjia Pharmaceutical Recent Developments/Updates
Table 105. Fredun Pharmaceuticals Ltd Corporation Information
Table 106. Fredun Pharmaceuticals Ltd Description and Business Overview
Table 107. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product
Table 109. Fredun Pharmaceuticals Ltd Recent Developments/Updates
Table 110. Supharma Chem Corporation Information
Table 111. Supharma Chem Description and Business Overview
Table 112. Supharma Chem Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Supharma Chem Albendazole Anthelmintic Drug Product
Table 114. Supharma Chem Recent Developments/Updates
Table 115. Salius Pharma Corporation Information
Table 116. Salius Pharma Description and Business Overview
Table 117. Salius Pharma Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Salius Pharma Albendazole Anthelmintic Drug Product
Table 119. Salius Pharma Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Albendazole Anthelmintic Drug Distributors List
Table 123. Albendazole Anthelmintic Drug Customers List
Table 124. Albendazole Anthelmintic Drug Market Trends
Table 125. Albendazole Anthelmintic Drug Market Drivers
Table 126. Albendazole Anthelmintic Drug Market Challenges
Table 127. Albendazole Anthelmintic Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Albendazole Anthelmintic Drug
Figure 2. Global Albendazole Anthelmintic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Albendazole Anthelmintic Drug Market Share by Type in 2023 & 2030
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Other Product Picture
Figure 7. Global Albendazole Anthelmintic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Albendazole Anthelmintic Drug Market Share by Application in 2023 & 2030
Figure 9. Human
Figure 10. Veterinary
Figure 11. Global Albendazole Anthelmintic Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Albendazole Anthelmintic Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Albendazole Anthelmintic Drug Sales (2019-2030) & (K Units)
Figure 14. Global Albendazole Anthelmintic Drug Average Price (US$/Unit) & (2019-2030)
Figure 15. Albendazole Anthelmintic Drug Report Years Considered
Figure 16. Albendazole Anthelmintic Drug Sales Share by Manufacturers in 2023
Figure 17. Global Albendazole Anthelmintic Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Albendazole Anthelmintic Drug Players: Market Share by Revenue in 2023
Figure 19. Albendazole Anthelmintic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Albendazole Anthelmintic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Albendazole Anthelmintic Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Albendazole Anthelmintic Drug Revenue Market Share by Country (2019-2030)
Figure 23. United States Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Albendazole Anthelmintic Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Albendazole Anthelmintic Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Albendazole Anthelmintic Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Albendazole Anthelmintic Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Albendazole Anthelmintic Drug Sales Market Share by Country (2019-2030)
Figure 44. Latin America Albendazole Anthelmintic Drug Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Albendazole Anthelmintic Drug Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Albendazole Anthelmintic Drug Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Albendazole Anthelmintic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Albendazole Anthelmintic Drug by Type (2019-2030)
Figure 54. Global Revenue Market Share of Albendazole Anthelmintic Drug by Type (2019-2030)
Figure 55. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Albendazole Anthelmintic Drug by Application (2019-2030)
Figure 57. Global Revenue Market Share of Albendazole Anthelmintic Drug by Application (2019-2030)
Figure 58. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Application (2019-2030)
Figure 59. Albendazole Anthelmintic Drug Value Chain
Figure 60. Albendazole Anthelmintic Drug Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
